Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers

NCT00247988 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT00247988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00247988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers
Lead sponsor
University of Saskatchewan
Phase
Phase 2
Overall status
Terminated
Start date
October 31, 2003
Completion date
April 30, 2007
Enrollment
38
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

platinum sensitive relapsed ovarian cancer